Salivary gland hyperplasia
Salivary gland hyperplasia is a medical condition characterized by the abnormal enlargement or proliferation of the salivary glands. This condition can affect any of the major or minor salivary glands, including the parotid gland, submandibular gland, and sublingual gland.
Causes[edit]
Salivary gland hyperplasia can be caused by a variety of factors. These include inflammation, infection, autoimmune diseases, and neoplasia. In some cases, the cause of the hyperplasia may be unknown, a condition referred to as idiopathic salivary gland hyperplasia.
Symptoms[edit]
The symptoms of salivary gland hyperplasia can vary depending on the gland affected and the severity of the condition. Common symptoms include swelling or enlargement of the affected gland, pain or discomfort, and difficulty swallowing or speaking. In some cases, there may also be changes in saliva production, such as xerostomia (dry mouth) or sialorrhea (excessive salivation).
Diagnosis[edit]
Diagnosis of salivary gland hyperplasia typically involves a combination of physical examination, medical history, and imaging studies such as ultrasound, computed tomography (CT) scan, or magnetic resonance imaging (MRI). In some cases, a biopsy may be performed to confirm the diagnosis and rule out other conditions such as salivary gland tumors.
Treatment[edit]
Treatment for salivary gland hyperplasia depends on the underlying cause and the severity of the condition. Options may include conservative management with observation and symptom control, medication to reduce inflammation or treat underlying conditions, and in some cases, surgical intervention to remove the affected gland.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian